Cargando…
Targeting tumor-associated macrophages for cancer treatment
Tumor-associated macrophages (TAMs) are abundant, nearly accounting for 30–50% of stromal cells in the tumor microenvironment. TAMs exhibit an immunosuppressive M2-like phenotype in advanced cancer, which plays a crucial role in tumor growth, invasion and migration, angiogenesis and immunosuppressio...
Autores principales: | Li, Mengjun, He, Linye, Zhu, Jing, Zhang, Peng, Liang, Shufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172100/ https://www.ncbi.nlm.nih.gov/pubmed/35672862 http://dx.doi.org/10.1186/s13578-022-00823-5 |
Ejemplares similares
-
Tumor-associated macrophages, potential targets for cancer treatment
por: Yang, Li, et al.
Publicado: (2017) -
Targeting tumor-associated macrophages in the tumor microenvironment
por: Zhou, Kaiwen, et al.
Publicado: (2020) -
Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
por: Zheng, Hongyu, et al.
Publicado: (2023) -
Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
por: Petty, Amy J., et al.
Publicado: (2021) -
Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy
por: He, Yuanyuan, et al.
Publicado: (2021)